Literature DB >> 28980924

STAT3 regulates cytokine expression in peripheral blood mononuclear cells from asthma patients.

Q Yang1, W Xu2, Y Long1, J Kuang1, J Li1.   

Abstract

Asthma is a common long term inflammatory disease of the airways. This disease affected millions of people worldwide. Recently, it is demonstrated that signal transducer and activator of transcription 3 (STAT3) plays critical role in asthma occurrence. In the current study, we isolated peripheral blood mononuclear cells (PBMCs) from patients with mild and moderate asthma, and then determined the correlation between STAT3 and cytokine expression. We found that the concentration and mRNA level of cytokines was increased in PBMCs from asthma patients. The concentration and mRNA level of cytokines was altered by the regulation of STAT3 expression and the concentration and mRNA expression level of cytokines was positively correlated with STAT3 activation. Furthermore, phosphorylated STAT3 expression in PBMCs from asthma patients was increased compared with the control. Collectively, this study directly proved that STAT3 was correlated with cytokine expression in PBMCs from asthma patients, providing a potential linkage between STAT3 and pathogenesis of asthma.

Entities:  

Keywords:  Asthma; Cytokine.; PBMCs; STAT3; p-STAT3

Mesh:

Substances:

Year:  2017        PMID: 28980924     DOI: 10.14715/cmb/2017.63.9.13

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  2 in total

1.  Suppression of autophagy through JAK2/STAT3 contributes to the therapeutic action of rhynchophylline on asthma.

Authors:  Hui Li; Qianyu Bi; Hongxia Cui; Chuanfeng Lv; Meng Wang
Journal:  BMC Complement Med Ther       Date:  2021-01-07

2.  Curcumin modulates airway remodelling-contributing genes-the significance of transcription factors.

Authors:  Joanna Wieczfinska; Przemysław Sitarek; Tomasz Kowalczyk; Piotr Rieske; Rafal Pawliczak
Journal:  J Cell Mol Med       Date:  2021-12-23       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.